Advertisement

Topics

FDA Reauthorization Act heads to Trump’s desk after Senate passage

15:19 EDT 3 Aug 2017 | Drug Store News

The bill contains the reauthorizations of the Food and Drug Administration’s Prescription Drug, Biosimilar, and Generic Drug User Fee Acts.

read more

Original Article: FDA Reauthorization Act heads to Trump’s desk after Senate passage

NEXT ARTICLE

More From BioPortfolio on "FDA Reauthorization Act heads to Trump’s desk after Senate passage"

Quick Search
Advertisement
 

Relevant Topics

Prescription Drugs
A prescription drug (also prescription medication or prescription medicine) is a licensed medicine that is regulated by legislation to require a medical prescription before it can be obtained. The term is used to distinguish it from over-the-counter drug...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...